25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Access Bio Inc
Buy, Hold or Sell?

Let's analyze Access Bio Inc together

I guess you are interested in Access Bio Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Access Bio Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Access Bio Inc

I send you an email if I find something interesting about Access Bio Inc.

1. Quick Overview

1.1. Quick analysis of Access Bio Inc (30 sec.)










1.2. What can you expect buying and holding a share of Access Bio Inc? (30 sec.)

How much money do you get?

How much money do you get?
₩0.04
When do you have the money?
1 year
How often do you get paid?
13.6%

What is your share worth?

Current worth
₩18,427.72
Expected worth in 1 year
₩36,841.67
How sure are you?
68.2%

+ What do you gain per year?

Total Gains per Share
₩18,472.77
Return On Investment
331.6%

For what price can you sell your share?

Current Price per Share
₩5,570.00
Expected price per share
₩5,180 - ₩6,350
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Access Bio Inc (5 min.)




Live pricePrice per Share (EOD)
₩5,570.00

2.2. Growth of Access Bio Inc (5 min.)




Is Access Bio Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$436.1m$338.6k$426.1m99.9%

How much money is Access Bio Inc making?

Current yearPrevious yearGrowGrow %
Making money-$2.7m-$1.1k-$2.7m-100.0%
Net Profit Margin-64.0%-45.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Access Bio Inc (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Access Bio Inc?

Welcome investor! Access Bio Inc's management wants to use your money to grow the business. In return you get a share of Access Bio Inc.

First you should know what it really means to hold a share of Access Bio Inc. And how you can make/lose money.

Speculation

The Price per Share of Access Bio Inc is ₩5,570. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Access Bio Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Access Bio Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩18,427.72. Based on the TTM, the Book Value Change Per Share is ₩4,603.49 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-0.28 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩14.71 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Access Bio Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.030.0%-0.080.0%0.000.0%0.180.0%0.150.0%
Usd Book Value Change Per Share0.300.0%3.220.1%0.000.0%0.630.0%0.590.0%
Usd Dividend Per Share0.000.0%0.010.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.300.0%3.230.1%0.000.0%0.630.0%0.590.0%
Usd Price Per Share4.65-6.15-7.06-5.52-5.62-
Price to Earnings Ratio36.75-9.95--5,862.61--468.40--350.08-
Price-to-Total Gains Ratio15.29-4.42--77,929.67--20,854.95--15,391.79-
Price to Book Ratio0.36-0.49-704.95-609.09-499.05-
Price-to-Total Gains Ratio15.29-4.42--77,929.67--20,854.95--15,391.79-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.899
Number of shares256
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.00
Usd Book Value Change Per Share3.220.63
Usd Total Gains Per Share3.230.63
Gains per Quarter (256 shares)827.58161.39
Gains per Year (256 shares)3,310.32645.58
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
111330033002643636
22166006610512861282
33298999920719301928
4421319913230925732574
55316499165401232163220
66319799198501438593866
77423098231601745024512
88426398264701951465158
99529698297802157895804
1010532998330902464326450

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%7.05.00.058.3%11.07.00.061.1%15.07.00.068.2%15.07.00.068.2%
Book Value Change Per Share3.01.00.075.0%8.04.00.066.7%12.06.00.066.7%15.07.00.068.2%15.07.00.068.2%
Dividend per Share2.00.02.050.0%3.00.09.025.0%3.00.015.016.7%3.00.019.013.6%3.00.019.013.6%
Total Gains per Share3.01.00.075.0%8.04.00.066.7%12.06.00.066.7%15.07.00.068.2%15.07.00.068.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Access Bio Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--434.2144603.488-91%-0.275+100%897.335-52%837.624-48%
Book Value Per Share--18427.71918017.823+2%14.278+128968%4010.186+360%3692.253+399%
Current Ratio--11.31910.528+8%5.149+120%4.577+147%8.434+34%
Debt To Asset Ratio--0.1380.146-5%0.284-51%0.350-60%0.301-54%
Debt To Equity Ratio--0.1610.172-6%0.411-61%0.677-76%0.554-71%
Dividend Per Share---14.705-100%0.168-100%3.305-100%2.704-100%
Eps--45.171-116.559+358%-0.050+100%255.908-82%212.099-79%
Free Cash Flow Per Share---338.371-763.633+126%-1036.192+206%-880.444+160%-880.444+160%
Free Cash Flow To Equity Per Share---338.371-763.633+126%-1037.136+207%-880.849+160%-880.849+160%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap188331726000.000-19%224510677360.000297206004607.500-24%341716942750.000-34%271799107190.556-17%275988159701.364-19%
Net Profit Margin--0.061-0.640+1151%-0.450+838%-0.175+387%-0.131+315%
Operating Margin----0%-0%117.471-100%96.118-100%
Operating Ratio--1.6114.163-61%1076.220-100%240.269-99%196.867-99%
Pb Ratio0.302-19%0.3600.488-26%704.950-100%609.091-100%499.050-100%
Pe Ratio30.827-19%36.7499.949+269%-5862.606+16053%-468.404+1375%-350.075+1053%
Price Per Share5570.000-19%6640.0008790.000-24%10080.000-34%7882.222-16%8034.545-17%
Price To Free Cash Flow Ratio-4.115+16%-4.906-2.070-58%-0.557-89%-0.584-88%-0.478-90%
Price To Total Gains Ratio12.828-19%15.2924.415+246%-77929.667+509711%-20854.951+136478%-15391.787+100753%
Quick Ratio--1.1311.643-31%4.674-76%2.114-46%3.738-70%
Return On Assets--0.002-0.006+367%-0.005+326%0.060-96%0.050-96%
Return On Equity--0.002-0.007+371%-0.004+267%0.106-98%0.086-97%
Total Gains Per Share--434.2144618.193-91%-0.107+100%900.640-52%840.328-48%
Usd Book Value--436152677.800426450987.900+2%338691.201+128676%94916483.305+360%87391136.341+399%
Usd Book Value Change Per Share--0.3043.222-91%0.000+100%0.628-52%0.586-48%
Usd Book Value Per Share--12.89912.612+2%0.010+128968%2.807+360%2.585+399%
Usd Dividend Per Share---0.010-100%0.000-100%0.002-100%0.002-100%
Usd Eps--0.032-0.082+358%0.000+100%0.179-82%0.148-79%
Usd Free Cash Flow---8008653.800-18073895.875+126%-18489142.175+131%-8125119.567+1%-6647825.100-17%
Usd Free Cash Flow Per Share---0.237-0.535+126%-0.725+206%-0.616+160%-0.616+160%
Usd Free Cash Flow To Equity Per Share---0.237-0.535+126%-0.726+207%-0.617+160%-0.617+160%
Usd Market Cap131832208.200-19%157157474.152208044203.225-24%239201859.925-34%190259375.033-17%193191711.791-19%
Usd Price Per Share3.899-19%4.6486.153-24%7.056-34%5.518-16%5.624-17%
Usd Profit--1069119.800-2758750.050+358%-1189.330+100%-594080.324+156%-421697.538+139%
Usd Revenue--17561307.40017412671.325+1%47700.749+36716%3931032.434+347%4272694.718+311%
Usd Total Gains Per Share--0.3043.233-91%0.000+100%0.630-52%0.588-48%
 EOD+3 -5MRQTTM+23 -11YOY+27 -75Y+19 -1610Y+18 -17

3.3 Fundamental Score

Let's check the fundamental score of Access Bio Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1530.827
Price to Book Ratio (EOD)Between0-10.302
Net Profit Margin (MRQ)Greater than00.061
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.131
Current Ratio (MRQ)Greater than111.319
Debt to Asset Ratio (MRQ)Less than10.138
Debt to Equity Ratio (MRQ)Less than10.161
Return on Equity (MRQ)Greater than0.150.002
Return on Assets (MRQ)Greater than0.050.002
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of Access Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.272
Ma 20Greater thanMa 505,838.000
Ma 50Greater thanMa 1006,141.000
Ma 100Greater thanMa 2006,705.000
OpenGreater thanClose5,530.000
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Access Bio Inc

Access Bio, Inc. engages in the research, development, and manufacture of in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products worldwide. The company provides Covid-19 detection kits, which are tests for assessing the current or past presence of SARS-CoV-2.; rapid diagnostic tests, suitable for preliminary diagnosis or emergency medical screening in medical facilities with limited resources; analyzers, designed to measure different chemicals and other characteristics in biological samples; and molecular diagnostic solutions used in analyzing biological markers in the genome and proteome. It offers its products under CareStart, CareUS, CareSURE, and CareGENE brand names. The company was incorporated in 2002 and is headquartered in Somerset, New Jersey.

Fundamental data was last updated by Penke on 2024-11-11 09:29:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Access Bio Inc earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Access Bio Inc to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 6.1% means that ₩0.06 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Access Bio Inc:

  • The MRQ is 6.1%. The company is making a profit. +1
  • The TTM is -64.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ6.1%TTM-64.0%+70.1%
TTM-64.0%YOY-45.0%-19.0%
TTM-64.0%5Y-17.5%-46.5%
5Y-17.5%10Y-13.1%-4.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ6.1%-4.0%+10.1%
TTM-64.0%-8.2%-55.8%
YOY-45.0%-0.8%-44.2%
5Y-17.5%-1.9%-15.6%
10Y-13.1%-0.3%-12.8%
4.3.1.2. Return on Assets

Shows how efficient Access Bio Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Access Bio Inc to the Diagnostics & Research industry mean.
  • 0.2% Return on Assets means that Access Bio Inc generated ₩0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Access Bio Inc:

  • The MRQ is 0.2%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is -0.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.2%TTM-0.6%+0.8%
TTM-0.6%YOY-0.5%-0.1%
TTM-0.6%5Y6.0%-6.6%
5Y6.0%10Y5.0%+1.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2%-1.2%+1.4%
TTM-0.6%-1.7%+1.1%
YOY-0.5%-0.9%+0.4%
5Y6.0%-0.1%+6.1%
10Y5.0%-0.5%+5.5%
4.3.1.3. Return on Equity

Shows how efficient Access Bio Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Access Bio Inc to the Diagnostics & Research industry mean.
  • 0.2% Return on Equity means Access Bio Inc generated ₩0.00 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Access Bio Inc:

  • The MRQ is 0.2%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -0.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.2%TTM-0.7%+0.9%
TTM-0.7%YOY-0.4%-0.3%
TTM-0.7%5Y10.6%-11.2%
5Y10.6%10Y8.6%+1.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2%-0.4%+0.6%
TTM-0.7%-1.7%+1.0%
YOY-0.4%0.3%-0.7%
5Y10.6%-0.9%+11.5%
10Y8.6%-0.9%+9.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Access Bio Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Access Bio Inc is operating .

  • Measures how much profit Access Bio Inc makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Access Bio Inc to the Diagnostics & Research industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Access Bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y11,747.1%-11,747.1%
5Y11,747.1%10Y9,611.8%+2,135.3%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--9.6%+9.6%
TTM--12.4%+12.4%
YOY-3.4%-3.4%
5Y11,747.1%1.4%+11,745.7%
10Y9,611.8%4.1%+9,607.7%
4.3.2.2. Operating Ratio

Measures how efficient Access Bio Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 1.61 means that the operating costs are ₩1.61 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Access Bio Inc:

  • The MRQ is 1.611. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.163. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.611TTM4.163-2.552
TTM4.163YOY1,076.220-1,072.057
TTM4.1635Y240.269-236.106
5Y240.26910Y196.867+43.402
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6111.311+0.300
TTM4.1631.294+2.869
YOY1,076.2201.242+1,074.978
5Y240.2691.208+239.061
10Y196.8671.191+195.676
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Access Bio Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Access Bio Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 11.32 means the company has ₩11.32 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Access Bio Inc:

  • The MRQ is 11.319. The company is very able to pay all its short-term debts. +2
  • The TTM is 10.528. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ11.319TTM10.528+0.791
TTM10.528YOY5.149+5.379
TTM10.5285Y4.577+5.952
5Y4.57710Y8.434-3.857
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ11.3192.028+9.291
TTM10.5282.090+8.438
YOY5.1492.484+2.665
5Y4.5772.668+1.909
10Y8.4343.230+5.204
4.4.3.2. Quick Ratio

Measures if Access Bio Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Access Bio Inc to the Diagnostics & Research industry mean.
  • A Quick Ratio of 1.13 means the company can pay off ₩1.13 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Access Bio Inc:

  • The MRQ is 1.131. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.643. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.131TTM1.643-0.512
TTM1.643YOY4.674-3.031
TTM1.6435Y2.114-0.471
5Y2.11410Y3.738-1.625
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1311.195-0.064
TTM1.6431.241+0.402
YOY4.6741.684+2.990
5Y2.1142.100+0.014
10Y3.7382.428+1.310
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Access Bio Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Access Bio Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Access Bio Inc to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.14 means that Access Bio Inc assets are financed with 13.8% credit (debt) and the remaining percentage (100% - 13.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Access Bio Inc:

  • The MRQ is 0.138. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.146. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.138TTM0.146-0.008
TTM0.146YOY0.284-0.139
TTM0.1465Y0.350-0.204
5Y0.35010Y0.301+0.049
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1380.437-0.299
TTM0.1460.440-0.294
YOY0.2840.359-0.075
5Y0.3500.428-0.078
10Y0.3010.450-0.149
4.5.4.2. Debt to Equity Ratio

Measures if Access Bio Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Access Bio Inc to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 16.1% means that company has ₩0.16 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Access Bio Inc:

  • The MRQ is 0.161. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.172. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.161TTM0.172-0.010
TTM0.172YOY0.411-0.239
TTM0.1725Y0.677-0.505
5Y0.67710Y0.554+0.123
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1610.640-0.479
TTM0.1720.686-0.514
YOY0.4110.515-0.104
5Y0.6770.666+0.011
10Y0.5540.712-0.158
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Access Bio Inc generates.

  • Above 15 is considered overpriced but always compare Access Bio Inc to the Diagnostics & Research industry mean.
  • A PE ratio of 36.75 means the investor is paying ₩36.75 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Access Bio Inc:

  • The EOD is 30.827. Based on the earnings, the company is overpriced. -1
  • The MRQ is 36.749. Based on the earnings, the company is overpriced. -1
  • The TTM is 9.949. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD30.827MRQ36.749-5.922
MRQ36.749TTM9.949+26.801
TTM9.949YOY-5,862.606+5,872.554
TTM9.9495Y-468.404+478.352
5Y-468.40410Y-350.075-118.328
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD30.827-0.360+31.187
MRQ36.749-0.693+37.442
TTM9.949-0.943+10.892
YOY-5,862.606-0.145-5,862.461
5Y-468.4041.937-470.341
10Y-350.0753.728-353.803
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Access Bio Inc:

  • The EOD is -4.115. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.906. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.070. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.115MRQ-4.906+0.791
MRQ-4.906TTM-2.070-2.836
TTM-2.070YOY-0.557-1.513
TTM-2.0705Y-0.584-1.486
5Y-0.58410Y-0.478-0.106
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-4.115-0.726-3.389
MRQ-4.906-1.123-3.783
TTM-2.070-1.081-0.989
YOY-0.557-2.356+1.799
5Y-0.584-2.252+1.668
10Y-0.478-2.248+1.770
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Access Bio Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 0.36 means the investor is paying ₩0.36 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Access Bio Inc:

  • The EOD is 0.302. Based on the equity, the company is cheap. +2
  • The MRQ is 0.360. Based on the equity, the company is cheap. +2
  • The TTM is 0.488. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.302MRQ0.360-0.058
MRQ0.360TTM0.488-0.128
TTM0.488YOY704.950-704.462
TTM0.4885Y609.091-608.603
5Y609.09110Y499.050+110.041
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD0.3022.247-1.945
MRQ0.3602.292-1.932
TTM0.4882.317-1.829
YOY704.9502.384+702.566
5Y609.0913.753+605.338
10Y499.0504.539+494.511
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets723,096,879
Total Liabilities100,021,625
Total Stockholder Equity620,380,504
 As reported
Total Liabilities 100,021,625
Total Stockholder Equity+ 620,380,504
Total Assets = 723,096,879

Assets

Total Assets723,096,879
Total Current Assets439,705,453
Long-term Assets283,391,427
Total Current Assets
Cash And Cash Equivalents 334,592,221
Short-term Investments 35,792,237
Net Receivables 8,145,548
Inventory 28,427,241
Other Current Assets 55,783
Total Current Assets  (as reported)439,705,453
Total Current Assets  (calculated)407,013,030
+/- 32,692,423
Long-term Assets
Property Plant Equipment 141,085,369
Intangible Assets 1,099,507
Long-term Assets  (as reported)283,391,427
Long-term Assets  (calculated)142,184,876
+/- 141,206,551

Liabilities & Shareholders' Equity

Total Current Liabilities38,845,505
Long-term Liabilities61,176,120
Total Stockholder Equity620,380,504
Total Current Liabilities
Short Long Term Debt 9,122,837
Accounts payable 1,005,449
Other Current Liabilities 399,590
Total Current Liabilities  (as reported)38,845,505
Total Current Liabilities  (calculated)10,527,876
+/- 28,317,629
Long-term Liabilities
Long term Debt 14,630,000
Capital Lease Obligations Min Short Term Debt50,845,989
Long-term Liabilities  (as reported)61,176,120
Long-term Liabilities  (calculated)65,475,989
+/- 4,299,869
Total Stockholder Equity
Retained Earnings 616,335,406
Total Stockholder Equity (as reported)620,380,504
Total Stockholder Equity (calculated)616,335,406
+/- 4,045,098
Other
Capital Stock2,544,314
Common Stock Shares Outstanding 33,812
Net Invested Capital 644,133,341
Net Working Capital 400,859,948
Property Plant and Equipment Gross 183,986,079



6.2. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312016-03-312015-12-312015-09-302015-06-30
> Total Assets 
78,409,000
82,855,000
81,121,000
91,744,000
60,985
67,414
74,303
156,419
294,215
261,177
263,819
372,846
882,555
782,053
733,052
698,714
748,351
555,559
726,018,359
691,136,495
712,494,883
723,096,879
723,096,879712,494,883691,136,495726,018,359555,559748,351698,714733,052782,053882,555372,846263,819261,177294,215156,41974,30367,41460,98591,744,00081,121,00082,855,00078,409,000
   > Total Current Assets 
50,963,000
51,961,000
45,784,000
54,105,000
24,654
35,204,591
40,756,478
111,945,425
253,652,349
177,601
179,777
276,837
761,375
655,150
604,712
564,779
619,246
419,356
502,921,919
418,432,916
438,362,894
439,705,453
439,705,453438,362,894418,432,916502,921,919419,356619,246564,779604,712655,150761,375276,837179,777177,601253,652,349111,945,42540,756,47835,204,59124,65454,105,00045,784,00051,961,00050,963,000
       Cash And Cash Equivalents 
6,923,000
7,988,000
7,025,000
14,913,000
0
1,629
2,753
45,225
57,509
3
4
4
4
6
124
8
37
95
314,258,758
277,606,819
340,379,222
334,592,221
334,592,221340,379,222277,606,819314,258,758953781246444357,50945,2252,7531,629014,913,0007,025,0007,988,0006,923,000
       Short-term Investments 
10,576,000
6,605,000
1,589,000
1,604,000
0
0
1,045
1,045
1,045
1,053
1,053
1,053
1,053
6,058
16,031
20,131
19,793
19,723
111,299,863
69,369,511
30,869,713
35,792,237
35,792,23730,869,71369,369,511111,299,86319,72319,79320,13116,0316,0581,0531,0531,0531,0531,0451,0451,045001,604,0001,589,0006,605,00010,576,000
       Net Receivables 
13,542,000
16,250,000
16,417,000
18,177,000
4,873
7,230,811
6,826,506
28,493,167
142,623,488
86,543
89,038
46,095
67,510
55,830
53,176
72,196
147,106
3,618
3,217,061
17,783,029
8,834,726
8,145,548
8,145,5488,834,72617,783,0293,217,0613,618147,10672,19653,17655,83067,51046,09589,03886,543142,623,48828,493,1676,826,5067,230,8114,87318,177,00016,417,00016,250,00013,542,000
       Inventory 
5,507,000
6,970,000
7,674,000
8,553,000
6,795
19,819,636
23,584,543
27,967,042
38,529,718
43,805
47,266
45,952
45,031
75,386
83,503
90,089
49,802
39,116
52,301,777
32,224,320
29,211,608
28,427,241
28,427,24129,211,60832,224,32052,301,77739,11649,80290,08983,50375,38645,03145,95247,26643,80538,529,71827,967,04223,584,54319,819,6366,7958,553,0007,674,0006,970,0005,507,000
       Other Current Assets 
1,309,000
4,231,000
4,597,000
3,392,000
165
3,107,349
4,442,333
4,547,247
3,426,012
0
11
6,016
813
334
346
374
361
359
470,464
103,485
48,386
55,783
55,78348,386103,485470,4643593613743463348136,0161103,426,0124,547,2474,442,3333,107,3491653,392,0004,597,0004,231,0001,309,000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
169,735,315
168,326,993
178,806,877
223,096,441
272,703,579
274,131,990
283,391,427
283,391,427274,131,990272,703,579223,096,441178,806,877168,326,993169,735,315000000000000000
       Property Plant Equipment 
0
0
0
0
25,754
33,495,137
34,467,840
49,124,526
67,003,329
62,245
63,518
67,976
92,302
93,071
93,082
130,547,046
135,437,643
139,693,905
140,461,318
139,505,935
140,387,903
141,085,369
141,085,369140,387,903139,505,935140,461,318139,693,905135,437,643130,547,04693,08293,07192,30267,97663,51862,24567,003,32949,124,52634,467,84033,495,13725,7540000
       Goodwill 
880,000
880,000
880,000
880,000
360
366
375
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000375366360880,000880,000880,000880,000
       Long Term Investments 
1,149,000
1,221,000
1,148,000
1,156,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000001,156,0001,148,0001,221,0001,149,000
       Intangible Assets 
0
0
0
0
3,873
3,874
3,867
1,784
1,678
1,619
1,518
1,449
1,369
1,280
1,166
1,161
1,084
1,055
1,317,526
1,203,009
1,156,051
1,099,507
1,099,5071,156,0511,203,0091,317,5261,0551,0841,1611,1661,2801,3691,4491,5181,6191,6781,7843,8673,8743,8730000
       Other Assets 
0
0
0
0
4,831
9,309,251
9,121,207
8,514,290
12,254,380
19,183
18,491
26,571
27,499
26,917
27,814
26,602
16,434
19,616
0
0
0
0
000019,61616,43426,60227,81426,91727,49926,57118,49119,18312,254,3808,514,2909,121,2079,309,2514,8310000
> Total Liabilities 
4,287,000
4,935,000
4,239,000
14,799,000
40,648
46,710
37,676
79,470
107,797
93,891
80,419
131,100
410,092
276,579
243,778
210,974
255,512
90,032
107,765,682
103,995,313
104,101,208
100,021,625
100,021,625104,101,208103,995,313107,765,68290,032255,512210,974243,778276,579410,092131,10080,41993,891107,79779,47037,67646,71040,64814,799,0004,239,0004,935,0004,287,000
   > Total Current Liabilities 
1,608,000
1,564,000
2,104,000
3,283,000
16,509
46,833,073
38,577,468
69,637,526
104,663,405
78,746
65,596
116,617
370,201
225,021
194,451
154,900
201,159
38,964
44,985,577
44,016,853
43,367,145
38,845,505
38,845,50543,367,14544,016,85344,985,57738,964201,159154,900194,451225,021370,201116,61765,59678,746104,663,40569,637,52638,577,46846,833,07316,5093,283,0002,104,0001,564,0001,608,000
       Short-term Debt 
257,000
387,000
326,000
10,248,000
3,068
17,343
20,162
23,459
22,491
14,690
13,841
13,834
13,545
0
0
0
0
0
0
0
0
0
00000000013,54513,83413,84114,69022,49123,45920,16217,3433,06810,248,000326,000387,000257,000
       Short Long Term Debt 
257,000
387,000
326,000
10,248,000
0
0
0
0
0
0
0
0
0
0
0
9,003,718
9,021,977
9,041,373
9,061,920
9,082,666
9,102,654
9,122,837
9,122,8379,102,6549,082,6669,061,9209,041,3739,021,9779,003,7180000000000010,248,000326,000387,000257,000
       Accounts payable 
332,000
390,000
591,000
582,000
0
5,445,760
2,914,879
4,728,483
4,912,651
0
0
0
0
0
0
2,195,753
1,164,059
1,236,747
1,120,533
3,458,828
1,031,876
1,005,449
1,005,4491,031,8763,458,8281,120,5331,236,7471,164,0592,195,7530000004,912,6514,728,4832,914,8795,445,7600582,000591,000390,000332,000
       Other Current Liabilities 
1,017,000
785,000
951,000
1,331,000
0
6,771,429
10,300,389
29,808,741
72,335,195
0
0
0
0
0
0
1,023,997
1,023,998
0
1,023,998
522,843
449,094
399,590
399,590449,094522,8431,023,99801,023,9981,023,99700000072,335,19529,808,74110,300,3896,771,42901,331,000951,000785,0001,017,000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
63,077,822
63,450,703
62,745,734
62,780,105
59,978,460
60,734,063
61,176,120
61,176,12060,734,06359,978,46062,780,10562,745,73463,450,70363,077,822000000000000000
       Long term Debt Total 
0
0
0
0
0
0
166
11,425
10,919
10,601
10,232
10,129
33,096
44,011
42,258
49,272
48,164
47,294
0
0
0
0
000047,29448,16449,27242,25844,01133,09610,12910,23210,60110,91911,425166000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
51,607,424
52,119,010
51,513,381
51,671,583
49,368,384
50,432,024
50,845,989
50,845,98950,432,02449,368,38451,671,58351,513,38152,119,01051,607,424000000000000000
       Other Liabilities 
0
0
0
0
0
1,000,000
999,999
1,435,201
2,025,992
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000002,025,9921,435,201999,9991,000,00000000
> Total Stockholder Equity
0
0
0
0
20,336
20,703
36,628
76,950
186,419
167,287
183,401
241,746
472,462
505,474
489,274
487,739
492,838
465,526
614,375,007
584,155,184
605,520,487
620,380,504
620,380,504605,520,487584,155,184614,375,007465,526492,838487,739489,274505,474472,462241,746183,401167,287186,41976,95036,62820,70320,3360000
   Retained Earnings 
16,955,000
18,839,000
18,802,000
19,148,000
-10,043
-11,854,721
-9,674,072
34,371,216
159,978,615
122,054
138,619
197,343
431,714
485,415
472,681
465,674
473,622
455,863
605,651,706
567,964,888
595,999,874
616,335,406
616,335,406595,999,874567,964,888605,651,706455,863473,622465,674472,681485,415431,714197,343138,619122,054159,978,61534,371,216-9,674,072-11,854,721-10,04319,148,00018,802,00018,839,00016,955,000
   Accumulated Other Comprehensive Income 0000000000000000000000
   Capital Surplus 
0
0
0
0
38,171
38,405
52,296
52,184
52,233
51,793
51,823
51,879
51,879
51,887
51,886
51,889
51,889
41,730
0
0
0
0
000041,73051,88951,88951,88651,88751,87951,87951,82351,79352,23352,18452,29638,40538,1710000
   Treasury Stock00000000000-3,855-3,855-3,855-3,855-3,855-3,855-3,9130000



6.3. Balance Sheets

Currency in KRW. All numbers in thousands.




6.4. Cash Flows

Currency in KRW. All numbers in thousands.




6.5. Income Statements

Currency in KRW. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue348,643,147
Cost of Revenue-178,381,142
Gross Profit170,262,005170,262,005
 
Operating Income (+$)
Gross Profit170,262,005
Operating Expense-326,721,476
Operating Income21,921,671-156,459,471
 
Operating Expense (+$)
Research Development16,080,517
Selling General Administrative170,639,071
Selling And Marketing Expenses-
Operating Expense326,721,476186,719,588
 
Net Interest Income (+$)
Interest Income14,432,501
Interest Expense-3,710,714
Other Finance Cost-0
Net Interest Income10,721,787
 
Pretax Income (+$)
Operating Income21,921,671
Net Interest Income10,721,787
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-5,879,34621,921,671
EBIT - interestExpense = -3,710,714
-3,172,838
537,876
Interest Expense3,710,714
Earnings Before Interest and Taxes (EBIT)--2,168,632
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-5,879,346
Tax Provision--580,477
Net Income From Continuing Ops-5,298,869-5,298,869
Net Income-3,172,838
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--10,721,787
 

Technical Analysis of Access Bio Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Access Bio Inc. The general trend of Access Bio Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Access Bio Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Access Bio Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 5,960 < 5,960 < 6,350.

The bearish price targets are: 5,180.

Tweet this
Access Bio Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Access Bio Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Access Bio Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Access Bio Inc. The current macd is -206.25031224.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Access Bio Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Access Bio Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Access Bio Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Access Bio Inc Daily Moving Average Convergence/Divergence (MACD) ChartAccess Bio Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Access Bio Inc. The current adx is 21.93.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Access Bio Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Access Bio Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Access Bio Inc. The current sar is 5,201.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Access Bio Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Access Bio Inc. The current rsi is 39.27. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Access Bio Inc Daily Relative Strength Index (RSI) ChartAccess Bio Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Access Bio Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Access Bio Inc price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Access Bio Inc Daily Stochastic Oscillator ChartAccess Bio Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Access Bio Inc. The current cci is -74.61084273.

Access Bio Inc Daily Commodity Channel Index (CCI) ChartAccess Bio Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Access Bio Inc. The current cmo is -20.34502524.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Access Bio Inc Daily Chande Momentum Oscillator (CMO) ChartAccess Bio Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Access Bio Inc. The current willr is -62.13592233.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Access Bio Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Access Bio Inc Daily Williams %R ChartAccess Bio Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Access Bio Inc.

Access Bio Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Access Bio Inc. The current atr is 216.10.

Access Bio Inc Daily Average True Range (ATR) ChartAccess Bio Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Access Bio Inc. The current obv is 131,210,770.

Access Bio Inc Daily On-Balance Volume (OBV) ChartAccess Bio Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Access Bio Inc. The current mfi is 28.73.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Access Bio Inc Daily Money Flow Index (MFI) ChartAccess Bio Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Access Bio Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-11BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-07-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-02BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-28MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-20STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Access Bio Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Access Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.272
Ma 20Greater thanMa 505,838.000
Ma 50Greater thanMa 1006,141.000
Ma 100Greater thanMa 2006,705.000
OpenGreater thanClose5,530.000
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Access Bio Inc with someone you think should read this too:
  • Are you bullish or bearish on Access Bio Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Access Bio Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Access Bio Inc

I send you an email if I find something interesting about Access Bio Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Access Bio Inc.

Receive notifications about Access Bio Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.